liew < life < lifelong

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 77.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000022 (2011)	Leonid Gibiansky [États-Unis] ; Nicolas Frey [États-Unis]	Linking interleukin-6 receptor blockade with tocilizumab and its hematological effects using a modeling approach
000056 (2015)	Yuliya Hellwig [Allemagne] ; Young E. Yoo [Allemagne] ; Marie L. Re [Allemagne] ; Oliver Andres [Allemagne] ; Matthias Braun [Allemagne] ; Paul G. Schlegel [Allemagne] ; Matthias Wölfl [Allemagne]	Fulminant skin GvHD with a cytokine pattern resemblant of cytokine release syndrome successfully treated with multimodal immunosuppression including tocilizumab
000066 (2013)	Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]	Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000075 (2011)	J. D. Alves [Portugal] ; A. Marinho [Portugal] ; M. J. Serra [Portugal]	Tocilizumab: is there life beyond anti‐TNF blockade?
000096 (2009)	Hiroe Sato [Japon] ; Takehito Sakai [Japon] ; Toshiaki Sugaya [Japon] ; Yasuhiro Otaki [Japon] ; Kana Aoki [Japon] ; Katsushi Ishii [Japon] ; Hidehiro Horizono [Japon] ; Hiroshi Otani [Japon] ; Asami Abe [Japon] ; Noboru Yamada [Japon] ; Hajime Ishikawa [Japon] ; Kiyoshi Nakazono [Japon] ; Akira Murasawa [Japon] ; Fumitake Gejyo [Japon]	Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
000101 (2012)	K. Krüger [Allemagne]	Medikamentöse Interaktionen in der Rheumatologie
000117 (2010)	C. B. Confavreux [France] ; R. D. Chapurlat [France]	Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
000125 (2012)	Nicolas Rohleder [États-Unis] ; Martin Aringer [Allemagne] ; Matthias Boentert [Allemagne]	Role of interleukin‐6 in stress, sleep, and fatigue
000130 (2007)	Gerald Gartlehner [Autriche, États-Unis] ; Richard A. Hansen [États-Unis] ; Beth L. Jonas [États-Unis] ; Patricia Thieda [États-Unis] ; Kathleen N. Lohr [États-Unis]	Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
000175 (2012)	P. Lehmann [Allemagne] ; E. Huber [Allemagne] ; T. Dörner [Allemagne] ; M. Fleck [Allemagne]	Makrophagenaktivierungssyndrom
000204 (2010)	C. J. Edwards [Royaume-Uni] ; E. Williams [Royaume-Uni]	The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
000292 (2010)	W. Graninger [Autriche]	Die immunmodulierende Therapie verbessert die Lebensqualität bei rheumatoider Arthritis
000306 (2013)	Pavel Horák [République tchèque] ; Martina Skácelová [République tchèque] ; Karel Hejduk [République tchèque] ; Andrea Smržová [République tchèque] ; Karel Pavelka [République tchèque]	Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
000392 (2013)	S. Bustabad ; J. J. Bethencourt ; M. Prieto Morales [Espagne] ; M. E. Peiro Callizo ; M. L. Gamir Gamir [Espagne]	AB0697 Tocilizumab in systemic and polyarticular juvenile idiopathic arthritis: results of a retrospective evaluation in real-life clinical practice
000473 (2013)	E. Nasonov ; E. Panasyuk ; E. Shikina [Russie] ; T. Plaksina ; A. Dmitrieva ; L. Troegubova [Russie]	AB0525 Local open-label multicenter study to evaluate the quality of life in patients with moderate to severe active rheumatoid arthritis and an inadequate response to DMARDS when adding tocilizumab
000475 (2013)	E. Panasyuk [Russie] ; E. Nasonov [Russie]	AB0310 Ra remission rates with tocilizumab therapy (lornet study: multicentre open-label, phase iv study of the quality of the life patient with severe/moderate ra with adding of tocilizumab to disease-modifying antirheumatic drugs therapy)
000478 (2013)	J. V. Tovar Beltrán ; M. A. Guzmán Beda ; I. Mateo Bernardo ; R. García-Vicu A [Espagne] ; M. Rodríguez-G Mez ; M. Belmonte-Serrano ; C. Marras ; E. Loza Cortina ; J. J. G Mez-Reino ; V. Vila ; A. B. Romero Silva ; A. Balsa [Espagne]	AB0540 Patterns of tocilizumab use, and dosing among patients with rheumatoid arthritis in the clinical practice. Preliminary analyses of act-life study
000510 (2013)	H. Pieringer [Autriche] ; U. C. Hoppe [Autriche]	Warum die rheumatoide Arthritis den Kardiologen braucht
000515 (2010)	Soomin Yoon [Corée du Sud] ; Yong-Sung Kim [Corée du Sud] ; Hyunbo Shim [Corée du Sud] ; Junho Chung [Corée du Sud]	Current perspectives on therapeutic antibodies
000527 (2013)	I. Ancuta ; C. Codreanu ; R. Ionescu ; M. Parvu [Roumanie] ; M. Bojinca	AB0537 Superior low disease activity and remission rates when rituximab is initiated after the first anti-TNF failure: Real life data
000535 (2013)	Oliver Foot ; Anshuman Malaviya	Treatment of rheumatoid arthritis: current and future

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "life" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "life" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    life
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021